Nazanin Farahbakhsh

Nazanin Farahbakhsh

Auto-generated profile, based on publicly available information

Nazanin Farahbakhsh

Department of Pediatric Pulmonology, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2016 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
SPShahnaz Pourarian
Shahnaz Pourarian
NFNazanin Farahbakhsh
Nazanin Farahbakhsh
DSDeepak Sharma
Deepak Sharma
SCSirous Cheriki
Sirous Cheriki
FBFarhad Bijanzadeh
Farhad Bijanzadeh
Background: Patent ductus arteriosus (PDA) is a common problem in the preterm infants. The frequency of PDA varies with the time of study, and the characteristics of the population included in the trial. Aims and objective: To determine the prevalence and prenatal risk factor associated with PDA. Methods and material: This prospective cross-sectional observational study was carried out on neonates who had gestational age below 37 weeks during the period of February 2014 to September 2014. Echocardiography was done at 4–7 days of postnatal age. The association between prenatal risk factors of the infants and the PDA was studied. Results: From a total population of 200 enrolled infants 22.5% had PDA. The mean gestational age and birth weight were 32.1 ± 2.65 (weeks) and 1741 ± 622.85 (g), respectively. Maternal antepartum hemorrhage, respiratory distress syndrome (RDS), need for surfactant, birth weights, female gender, gestational age, Apgar scores at 1 and 5 min of the infants were found to be associated with the prevalence of PDA. Conclusion: Several prenatal factors make preterm newborns susceptible to PDA. These risk factors should be identified as soon as possible for early commencement of PDA management.

5 June 2019 in The Korean Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
LMLeily Mohajerzadeh
Leily Mohajerzadeh
SLSaran Lotfollahzadeh
Saran Lotfollahzadeh
AVArmin Vosoughi
Armin Vosoughi
IHIman Harirforoosh
Iman Harirforoosh
SPSina Parsay
Sina Parsay
KAKhashayar Atqiaee
Khashayar Atqiaee
To compare the outcomes of video-assisted thoracoscopic surgery (VATS) in comparison to open thoracic surgery in pediatric patients suffering from empyema. A prospective study was carried out in 80 patients referred to the Department of Pediatric Surgery between 2015 and 2018. The patients were randomly divided into thoracotomy and VATS groups (groups I and II, respectively). Forty patients were in the thoracotomy group (16 males [40%], 24 females [60%]; average age, 5.77±4.08 years) and 40 patients were in the VATS group (18 males [45%], 22 females [55%]; average age, 6.27±3.67 years). There were no significant differences in age (p=0.61) or sex (p=0.26). Routine preliminary workups for all patients were ordered, and the patients were followed up for 90 days at regular intervals. The average length of hospital stay (16.28±7.83 days vs. 15.83±9.44 days, p=0.04) and the duration of treatment needed for pain relief (10 days vs. 5 days, p=0.004) were longer in the thoracotomy group than in the VATS group. Thoracotomy patients had surgical wound infections in 27.3% of cases, whereas no cases of infection were reported in the VATS group (p=0.04). Our results indicate that VATS was not only less invasive than thoracotomy, but also showed promising results, such as an earlier discharge from the hospital and fewer postoperative complications.

6 February 2020 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
STSeyed Ahmad Tabatabaii
Seyed Ahmad Tabatabaii
GKGhamartaj Khanbabaee
Ghamartaj Khanbabaee
SSSaeed Sadr
Saeed Sadr
NFNazanin Farahbakhsh
Nazanin Farahbakhsh
MAMaryam Kazemi Aghdam
Maryam Kazemi Aghdam
FGFatemeh Abdollah Gorji
Fatemeh Abdollah Gorji
Background: Early detection of pulmonary contamination in children with cystic fibrosis (CF) is essential since these children are vulnerable toPseudomonas aeruginosa(P. aeruginosa) colonization. In Iran, home nebulization of antibiotics is a widespread practice in treatment for patients with CF and, to the best our knowledge, no bacteriological surveys have been conducted till date in this regard.Method: This observational, cross sectional study was conducted on 61 children with CF at Mofid Children’s Hospital, Tehran, from September 2017 to march 2018. The swab sampling was performed from 61 home nebulizers used by children diagnosed with CF. Contemporaneous sputum sample or deep nasopharyngeal swab was taken from each patient for bacterial and fungal testing. Medical records of the patients were reviewed and the number of exacerbations were recorded over the last 12 months prior to the study enrollment.Results: The results of study showed that, 43 (70.5%) nebulizers were contaminated; 31 (50.8%) mouthpieces, 21 (34.4%) reservoirs, and 11 (18%) connecting tubes. The most common organism to be isolated wasP. aeruginosaand was recovered from 19 (31%) nebulizers, 16 of them belonged to patients chronically colonized withP. aeruginosa. The remaining three had at least one positive sputum culture forP. aeruginosain the past 1 year before the study. There was a significant increase in the number of CF exacerbations with an average number of exacerbation being 1.5 ± 1(SD) over last 12 months in children who had pathogenic organisms recovered from their home nebulizers compared with 0.4 ± 0.7(SD) exacerbations per year in whom non-pathogenic organisms were isolated from their nebulizers (P < 0.001).Conclusion: The majority of domiciliary nebulizers used by children with CF were contaminated with microorganisms indicating that the nebulizers may serve as potential reservoirs of pathogens for the patients’ lung. Perpetuating colonization is a possible concern in the ones recently colonized withP. aeruginosaand, therefore, decontamination of nebulizer requires more attention to prevent ongoing infection. The negative impact of contamination of nebulizer on CF exacerbation requires serious attention and further investigations.

19 September 2020 in Archives of Pediatric Infectious Diseases
Verified
Journal Article
Open access
PDF file
STSeyed Ahmad Tabatabaii
Seyed Ahmad Tabatabaii
PSPegah Soltani
Pegah Soltani
GKGhamartaj Khanbabaee
Ghamartaj Khanbabaee
DSDeepak Sharma
Deepak Sharma
RVRohollah Valizadeh
Rohollah Valizadeh
ETEbrahim Tabiei
Ebrahim Tabiei
Context: Coronavirus Disease 2019 (COVID-19) pandemic has caused irreparable damage to society. The pediatric population may be asymptomatic but has positive viral nucleic acid test results and plays an important role in spreading the infection in populations. However, there is a substantial information gap on the epidemiology, pathology, and clinical presentations of COVID-19 in pediatric patients. Evidence Acquisition: English research articles published before April 18, 2020, were reviewed to understand the clinical characteristics of SARS coronavirus 2, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome in children. The WHO (https://www.who. int/) and CDC (Centers for Disease Control and Prevention, https://www.cdc.gov/) websites were also reviewed to find eligible studies, besides articles extracted from PubMed, Scopus, and Google Scholar. Results: In comparison with SARS and MERS, COVID-19 seems to have wider clinical symptoms and routes of transmission. Multisystem inflammatory syndrome is a unique clinical feature of this novel virus. The low prevalence of COVID-19 in children may be due to lower contacts or incomplete identification rather than resistance to the virus. Conclusions: As this virus is novel, we believe that lessons learned from SARS and MERS outbreaks are very valuable in handling the current pandemic. The aim of this paper was to provide the updated summary of clinical manifestation, diagnostic, molecular, and genetic aspects of the novel coronavirus in comparison with SARS and MERS coronaviruses in children.

8 February 2021 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
MTMarjan Tariverdi
Marjan Tariverdi
NFNazanin Farahbakhsh
Nazanin Farahbakhsh
HGHamed Gouklani
Hamed Gouklani
FKFatemeh Khosravifar
Fatemeh Khosravifar
MTMohammad Tamaddondar
Mohammad Tamaddondar
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has caused irreparable damage to society, and the damage continues. Pediatricians are confronted with COVID-19 in a variety of presentations, which may lead to delayed diagnosis and treatment. Early diagnosis of the disease plays an important role in preventing transmission of the virus in the community. Case presentation: Here we report a 27-month-old previously healthy Iranian female child who presented with fever and bloody diarrhea, diagnosed with COVID-19 based on contact history, exclusion of enteric bacterial pathogens and parasites, and positive stool and nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase polymerase chain reaction (RT-PCR) tests. The patient had viral shedding for more than a month. Conclusions: The pediatric population usually does not present with typical clinical features of COVID-19, which are respiratory involvement. Dysentery may be the only presentation of this disease, and long-term isolation should be considered, as the viral shedding may last for more than a month.

8 January 2018 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
DSDeepak Sharma
Deepak Sharma
NFNazanin Farahbakhsh
Nazanin Farahbakhsh
A term male infant was admitted at 48 h of postnatal life to the neonatal unit for jaundice. The investigation showed total serum bilirubin (TSB) of 17.1 mg/dl, haemoglobin of 11 g/dl, reticulocyte count of 9.5% and peripheral smear was suggestive of macrocytic, normochromic red blood cell (RBC) with target cells and multiple spherocytes with occasional nucleated RBC. The infant’s blood group was B positive. Direct antiglobulin test was strongly positive by gel method (3+). Mother’s blood group was B positive and indirect antiglobulin test was positive when tested postnatally. Extended minor blood grouping and cross matching showed this as a case of combined anti e and anti C antibodies isoimmunisation. Infant was treated with phototherapy for 72 h and was shifted to mother side. Infant was serially monitored with TSB level every sixth hourly and American Academy of Pediatrics (AAP) phototherapy charts were followed to see for rebound hyperbilirubinemia. The neonate was discharged and there was no readmission for hyperbilirubinemia. It is very rare and we report the third case of its type till date.